Augustine Lawlor - Chief Operating Officer at Leap Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Operating Officer
Stock Symbol
LPTX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Augustine Lawlor since 4/23/2024

Holdings reported by Augustine Lawlor for Leap Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 678K $215K $0.32 Mar 28, 2025 Indirect
Common Stock 19.8K $6.27K $0.32 Mar 28, 2025 Direct
Restricted Stock Units 0 $0 $0.32 Mar 28, 2025 Direct Common Stock
Employee Stock Option (Right to Buy) 85K Oct 2, 2024 Direct Common Stock
Warrant (Right to Buy) 0 Nov 13, 2024 Indirect Common Stock, $0.001 par value per share

Transactions reported by Augustine Lawlor for Leap Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.